shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
Z5256039149,Z5256039149,C20H16ClN3O2,Racemic diastereomer with known relative stereochemistry,365.812,100,COVID-19,,,0,40,20,1178796-Y40-81,03_A,"C[C@@H]1NC(=O)C=2C=CC(Cl)=CC2[C@@H]1C(=O)NC=3C=NC=C4C=CC=CC34 |&1:1,12,r|","rac-(3R,4R)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3381526,5.4
EDJ-MED-12c4873b-5-1,Z5352411776,C23H21ClN4O2,Racemic diastereomer with known relative stereochemistry,420.891,93,COVID-19,,,0,40,20,1178796-Y40-81,03_B,"ClC=1C=CC=2CN(C[C@@H](C(=O)NC=3C=NC=C4C=CC=CC34)C2C1)[C@@H]5CCNC5=O |&1:8,24,r|","rac-(4R)-6-chloro-N-(isoquinolin-4-yl)-2-[(3S)-2-oxopyrrolidin-3-yl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3428034,7
EDJ-MED-7889e8da-6,Z5210381227,C25H23ClN4O5S2,Racemic or presumed racemic or meso,559.056,98.72,COVID-19,,,0,40,20,1178796-Y40-81,03_C,CS(=O)(=O)C=1C=CC=2C(NC(=O)C3CN(CC=4C=CC(Cl)=CC34)S(=O)(=O)CC5(CC5)C#N)=CN=CC2C1,"6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-(7-methanesulfonylisoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3521242,43.2
EDJ-MED-2791eece-12,Z5278655719,C21H19ClN4O2,Racemic or presumed racemic or meso,394.854,95.73,COVID-19,,,0,40,20,1178796-Y40-81,03_D,CNC(=O)N1CCC=2C=CC(Cl)=CC2C1C(=O)NC=3C=NC=C4C=CC=CC34,"7-chloro-N1-(isoquinolin-4-yl)-N2-methyl-1,2,3,4-tetrahydroisoquinoline-1,2-dicarboxamide",H3490138,31.1
Z5338006060,Z5338006060,C24H22ClN5O3S,Single unknown enantiomer,495.981,100,COVID-19,,,0,40,20,1178796-Y40-81,03_E,"ClC=1C=CC=2CN(C[C@H](C(=O)NC=3C=NC=C4C=CC=CC34)C2C1)S(=O)(=O)CC5(CNC5)C#N |o1:8,r|","rel-(4R)-6-chloro-2-[(3-cyanoazetidin-3-yl)methanesulfonyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3512774,5.9
Z5338006057,Z5338006057,C24H22ClN5O3S,Single unknown enantiomer,495.981,100,COVID-19,,,0,40,20,1178796-Y40-81,03_F,"ClC=1C=CC=2CN(C[C@@H](C(=O)NC=3C=NC=C4C=CC=CC34)C2C1)S(=O)(=O)CC5(CNC5)C#N |o1:8,r|","rel-(4R)-6-chloro-2-[(3-cyanoazetidin-3-yl)methanesulfonyl]-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3512775,7
EDJ-MED-c3ea9889-5,Z5335933734,C21H17ClN2O4S,Diastereomeric mixture,428.888,100,COVID-19,,,0,40,20,1178796-Y40-81,03_G,CS(=O)(=O)C=1C=CC=2C(NC(=O)C3(CC4C3)C=5C=C(Cl)C=CC5O4)=CN=CC2C1,"4-chloro-N-(7-methanesulfonylisoquinolin-4-yl)-8-oxatricyclo[7.1.1.0?,?]undeca-2(7),3,5-triene-1-carboxamide",H3517546,66.5
EDJ-MED-c3ea9889-8,Z5335933739,C20H14Cl2N2O2,Diastereomeric mixture,385.243,100,COVID-19,,,0,40,20,1178796-Y40-81,03_H,ClC=1C=CC=2OC3CC(C3)(C(=O)NC=4C=NC=C5C=CC=C(Cl)C45)C2C1,"4-chloro-N-(5-chloroisoquinolin-4-yl)-8-oxatricyclo[7.1.1.0?,?]undeca-2(7),3,5-triene-1-carboxamide",H3517538,68.7
EDJ-MED-e69ed63d-12,Z5335933832,C26H27ClN4O5S,Racemic or presumed racemic or meso,543.034,100,COVID-19,,,0,40,20,1178796-Y40-81,03_I,CC(C)(C)NC(=O)CN1CC(C(=O)NC=2C=NC=C3C=C(C=CC23)S(=O)(=O)C)C=4C=C(Cl)C=CC4C1=O,"2-[(tert-butylcarbamoyl)methyl]-6-chloro-N-(7-methanesulfonylisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3513033,57.9
EDJ-MED-e69ed63d-11,Z5335933827,C25H24ClFN4O3,Racemic or presumed racemic or meso,482.934,100,COVID-19,,,0,40,20,1178796-Y40-81,03_J,CC(C)(C)NC(=O)CN1CC(C(=O)NC=2C=NC=C3C=C(F)C=CC23)C=4C=C(Cl)C=CC4C1=O,"2-[(tert-butylcarbamoyl)methyl]-6-chloro-N-(7-fluoroisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3512353,80.5
EDJ-MED-1b46f08e-1,Z5335933775,C22H22ClN3O5S,Racemic or presumed racemic or meso,475.945,100,COVID-19,,,0,40,20,1178796-Y40-81,03_K,COC1(CCOC=2C=CC(Cl)=CC21)C(=O)NC=3C=NC=C4C=C(C=CC34)S(=O)(=O)N(C)C,"6-chloro-N-[7-(dimethylsulfamoyl)isoquinolin-4-yl]-4-methoxy-3,4-dihydro-2H-1-benzopyran-4-carboxamide",H3523420,48.9
EDJ-MED-e69ed63d-4,Z5335933793,C25H23ClN4O5S,Racemic or presumed racemic or meso,526.991,100,COVID-19,,,0,40,20,1178796-Y40-81,03_L,CS(=O)(=O)C=1C=CC=2C(NC(=O)C3CN(CC(=O)NC4CC4)C(=O)C=5C=CC(Cl)=CC35)=CN=CC2C1,"6-chloro-2-[(cyclopropylcarbamoyl)methyl]-N-(7-methanesulfonylisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3515849,31.7
EDJ-MED-e69ed63d-7,Z5335933813,C23H20ClFN4O3,Racemic or presumed racemic or meso,454.881,100,COVID-19,,,0,40,20,1178796-Y40-81,03_M,CCNC(=O)CN1CC(C(=O)NC=2C=NC=C3C=C(F)C=CC23)C=4C=C(Cl)C=CC4C1=O,"6-chloro-2-[(ethylcarbamoyl)methyl]-N-(7-fluoroisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3517544,87.6
EDJ-MED-e69ed63d-10,Z5335933824,C26H25ClN4O5S,Racemic or presumed racemic or meso,541.018,98.08,COVID-19,,,0,40,20,1178796-Y40-81,03_N,CS(=O)(=O)C=1C=CC=2C(NC(=O)C3CN(CC(=O)NC4CCC4)C(=O)C=5C=CC(Cl)=CC35)=CN=CC2C1,"6-chloro-2-[(cyclobutylcarbamoyl)methyl]-N-(7-methanesulfonylisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3515851,58.1
EDJ-MED-e69ed63d-8,Z5335933818,C24H23ClN4O5S,Racemic or presumed racemic or meso,514.981,100,COVID-19,,,0,40,20,1178796-Y40-81,03_O,CCNC(=O)CN1CC(C(=O)NC=2C=NC=C3C=C(C=CC23)S(=O)(=O)C)C=4C=C(Cl)C=CC4C1=O,"6-chloro-2-[(ethylcarbamoyl)methyl]-N-(7-methanesulfonylisoquinolin-4-yl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3513226,45.2
MAT-POS-c7726e07-3,Z5370893186,C22H18ClFN4O3,Single unknown enantiomer,440.854,100,COVID-19,,,0,40,20,1178796-Y40-81,03_P,"CNC(=O)CN1C[C@H](C(=O)NC=2C=NC=C3C=CC(F)=CC23)C=4C=C(Cl)C=CC4C1=O |o1:7,r|","rel-(4R)-6-chloro-N-(6-fluoroisoquinolin-4-yl)-2-[(methylcarbamoyl)methyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3538822,9
EDJ-MED-12c4873b-2,Z5261485073,C24H21ClN4O3,Racemic or presumed racemic or meso,448.901,100,COVID-19,,,0,40,20,1178796-Y40-81,04_A,CNC(=O)C1(CC1)N2CC(C(=O)NC=3C=NC=C4C=CC=CC34)C=5C=C(Cl)C=CC5C2=O,"6-chloro-N-(isoquinolin-4-yl)-2-[1-(methylcarbamoyl)cyclopropyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3532697,82.7
EDJ-MED-12c4873b-8,Z5261485079,C23H19ClN4O3,Diastereomeric mixture,434.874,100,COVID-19,,,0,40,20,1178796-Y40-81,04_B,ClC=1C=CC=2C(=O)N(CC(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1)C5CNC(=O)C5,"6-chloro-N-(isoquinolin-4-yl)-1-oxo-2-(5-oxopyrrolidin-3-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3532693,68.7
MAT-POS-c7726e07-4,Z5370893187,C22H18ClFN4O3,Single unknown enantiomer,440.854,100,COVID-19,,,0,40,20,1178796-Y40-81,04_C,"CNC(=O)CN1C[C@@H](C(=O)NC=2C=NC=C3C=CC(F)=CC23)C=4C=C(Cl)C=CC4C1=O |o1:7,r|","rel-(4R)-6-chloro-N-(6-fluoroisoquinolin-4-yl)-2-[(methylcarbamoyl)methyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3538821,8.6
MAT-POS-c88128cb-14,Z5367986302,C20H18ClN3O5S2,Racemic or presumed racemic or meso,479.957,100,COVID-19,,,0,40,20,1178796-Y40-81,04_D,CC1(CNS(=O)(=O)C=2C=CC(Cl)=CC21)C(=O)NC=3C=NC=C4C=C(C=CC34)S(=O)(=O)C,"6-chloro-N-(7-methanesulfonylisoquinolin-4-yl)-4-methyl-1,1-dioxo-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3540040,1.6
MAT-POS-c88128cb-12,Z5367986300,C19H15ClFN3O3S,Racemic or presumed racemic or meso,419.857,90.22,COVID-19,,,0,40,20,1178796-Y40-81,04_E,CC1(CNS(=O)(=O)C=2C=CC(Cl)=CC21)C(=O)NC=3C=NC=C4C=CC(F)=CC34,"6-chloro-N-(6-fluoroisoquinolin-4-yl)-4-methyl-1,1-dioxo-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3540036,1.8
ALP-POS-1cbc2fae-2,Z5115885783,C20H18ClN3O3S,Racemic or presumed racemic or meso,415.893,98.25,COVID-19,,,0,40,20,1178796-Y40-81,04_F,CCC1(CNS(=O)(=O)C=2C=CC(Cl)=CC21)C(=O)NC=3C=NC=C4C=CC=CC34,"6-chloro-4-ethyl-N-(isoquinolin-4-yl)-1,1-dioxo-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3540031,7.4
ALP-POS-1460fd94-1,Z5261485070,C24H25ClN4O3,Racemic or presumed racemic or meso,452.933,100,COVID-19,,,0,40,20,1178796-Y40-81,04_G,CNC(=O)CN1CC(C(=O)NC=2C=NC=C3C=C(COC)C=CC23)C=4C=C(Cl)C=CC4C1,"6-chloro-N-[7-(methoxymethyl)isoquinolin-4-yl]-2-[(methylcarbamoyl)methyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3544328,9.4
EDJ-MED-12c4873b-6,Z5261485077,C23H19ClN4O3,Diastereomeric mixture,434.874,93,COVID-19,,,0,40,20,1178796-Y40-81,04_H,ClC=1C=CC=2C(=O)N(CC(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1)C5CCNC5=O,"6-chloro-N-(isoquinolin-4-yl)-1-oxo-2-(2-oxopyrrolidin-3-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3532699,6.8
MAT-POS-c7726e07-6,Z5370893189,C24H23ClN4O2,Single unknown enantiomer,434.918,100,COVID-19,,,0,40,20,1178796-Y40-81,04_I,"CNC(=O)CN1CC=2C=CC(Cl)=CC2[C@]3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C1 |o1:14,r|","rel-2-[(4R)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3537745,0
MAT-POS-c7726e07-5,Z5370893188,C24H23ClN4O2,Single unknown enantiomer,434.918,100,COVID-19,,,0,40,20,1178796-Y40-81,04_J,"CNC(=O)CN1CC=2C=CC(Cl)=CC2[C@@]3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C1 |o1:14,r|","rel-2-[(4R)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3537744,0
EDJ-MED-c3ea9889-4,Z5367986368,C22H20Cl2N4O4S,Racemic or presumed racemic or meso,507.389,96.48,COVID-19,,,0,40,20,1178796-Y40-81,04_K,CNC(=O)CN1CC(C)(C(=O)NC=2C=NC=C3C=CC=C(Cl)C23)C=4C=C(Cl)C=CC4S1(=O)=O,"6-chloro-N-(5-chloroisoquinolin-4-yl)-4-methyl-2-[(methylcarbamoyl)methyl]-1,1-dioxo-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3540038,0